Genes for schizophrenia? Recent findings and their pathophysiological implications

Lancet

Volumn 361, Issue 9355, 2003, Pages 417-419

  Harrison, Paul J ^a   Owen, Michael J ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR;

ALZHEIMER DISEASE; EPISTASIS; GENETIC ANALYSIS; HERITABILITY; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; SHORT SURVEY;

EID: 0037308528     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12379-3     Document Type: Short Survey

References (33)

1. Owen M.J., O'Donovan M., Gottesman I.I. Psychiatric genetics and genomics. 2003;247-266 Oxford University Press, Oxford.
2. Badner J.A., Gershon E.S. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry. 7:2002;405-411.
3. Levinson D.F., Lewis C.M., Wise L.H., et al. Meta-analysis of genome scans for schizophrenia. Am J Med Genet. 114:2002;700-701. abstr.
4. Cioninger C.R. The discovery of susceptibility genes for mental disorders. Proc Natl Acad Sci USA. 99:2002;13365-13367.
5. Stefansson H., Sigurdsson E., Steinhorsdottir V., et al. Neuregulin1 and susceptibility to schizophrenia. Am J Hum Genet. 71:2002;877-892.
6. Stefansson H., Sarginson J., Kong A., et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet. 72:2003;83-87.
7. Straub RE, Jiang Y, MacLean CJ, et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337-48. (Published erratum appears in Am J Hum Genet 2002; 71: 1007.).
8. Schwab S.G., Knapp M., Mondabon S., et al. Support for an association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet. 72:2003;185-190.
9. Chumakov I., Blumenfeld M., Guerassimenko O., et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA. 99:2002;13675-13680.
10. Chowdhari K.V., Mirnics K., Semwal P., et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet. 11:2002;1373-1380.
11. Mirnics K., Middleton F.A., Marquez A., et al. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 28:2000;53-67.
12. Brzustowicz L.M., Hodgkinson K.A., Chow E.W.C., et al. Location of a major susceptibility locus for familial schizophrenia on chromosome 1q21-q22. Science. 288:2000;678-682.
13. Liu H., Heath S.C., Sobin C., et al. Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia. Proc Natl Acad Sci USA. 99:2002;3717-3722.
14. Murphy K.C. Schizophrenia and velo-cardio-facial syndrome. Lancet. 359:2002;426-430.
15. Gogos J.A., Santha M., Takacs Z., et al. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nat Genet. 21:1999;434-439.
16. Williams HJ, Williams N, Spurlock G, et al. Association between PRODH and schizophrenia not confirmed. Mol Psychiatry (in press).
17. Shifman S., Bronstein M., Sternfeld M., et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet. 71:2002;1296-1302.
18. Egan M.F., Goldberg T.E., Kolachana B.S., et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA. 98:2001;6917-6922.
19. Gogos J.A., Morgan M., Luine V., et al. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA. 95:1998;9991-9996.
20. Akil M, Kolachana BS, Rothmond DA, et al. COMT genotype and dopamine regulation in the human brain. J Neurosci (in press).
21. Mackay T.F. Quantitative trait loci in Drosophila. Nat Rev Genet. 2:2001;11-20.
22. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 44:1987;660-669.
23. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci. 25:2002;409-432.
24. Harrison P.J. The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain. 122:1999;593-624.
25. Tsai G.C., Coyle J.T. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol. 42:2002;165-179.
26. Mothet J.-P., Parent A.T., Wolosker H., et al. D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci USA. 97:2000;4926-4931.
27. Buonanno A., Fischbach G.D. Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr Opin Neurobiol. 11:2001;28-96.
28. De Blasi A., Conn P.J., Pin J.-P., Nicoletti F. Molecular determinants of metabotropic glutamate receptor signalling. Trends Pharmacol Sci. 22:2001;114-120.
29. De Vries L., Zheng B., Fischer T., et al. The regulator of G protein signalling family. Annu Rev Pharmacol Toxicol. 40:2000;235-271.
30. Benson M.A., Newey S.A., Martin-Rendon E., et al. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem. 276:2001;24232-24341.
31. Grace A.A. Phasic versus tonic dopamine release and modulation of glutamate system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience. 41:1991;1-24.
32. Leonard S., Gault J., Hopkins J., et al. Association of promoter variants in the α7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch Gen Psychiatry. 59:2002;1085-1096.
33. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:2002;353-356.